HR Execs on the Move

The Primary Health Network

www.primary-health.net

 
The Primary Health Network is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Sharon, PA. To find more information about The Primary Health Network, please visit www.primary-health.net
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Tina Adamson
Chief Human Profile

Similar Companies

Acelity

Acelity is a global market leader in advanced wound therapeutics and regenerative medicine, offering innovative solutions from the hospital to home that improve the lives of patients in more than 80 countries. Our mission is to change the practice of medicine with solutions that speed healing, create economic value and improve patients’ lives. We are the undisputed leader in negative pressure wound therapy, the number one provider of regenerative tissue products used for breast reconstruction and hernia repair, and the market leader in collagen dressings. Acelity is headquartered in San Antonio, Texas, with more than 5,800 employees around the globe.

Interstate Imaging

Interstate Imaging is a Evansville, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CarePayment

Out-of-pocket healthcare expenses are on the rise, which means patients are having difficulty paying their share and providers are finding it difficult to collect from those patients. It`s a lose-lose situation. CarePayment offers a unique solution that helps patients meet their financial obligations and protect their financial health while helping providers stay financially healthy by reducing bad debt and improving cash flow.

OncoGenex

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.

Catholic Medical Center - New Hampshire

Catholic Medical Center - New Hampshire is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Catholic Medical Center - New Hampshire is based in Manchester, NH. You can find more information on Catholic Medical Center - New Hampshire at www.cmc-nh.org